BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.53M | 10.31M | 535.00K | -26.88M | -54.31M |
| Total Depreciation and Amortization | 3.62M | 2.24M | 3.13M | 2.31M | 3.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 21.50M | -240.00K | 1.31M | 25.71M | 43.90M |
| Change in Net Operating Assets | -4.04M | -4.13M | -3.01M | 1.50M | 699.00K |
| Cash from Operations | 15.54M | 14.63M | 8.43M | 9.10M | -84.00K |
| Capital Expenditure | -4.68M | -2.78M | -3.17M | -4.75M | -5.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.93M | 47.56M | 74.91M | 6.81M | 11.00M |
| Cash from Investing | 5.25M | 31.35M | 58.30M | -11.38M | -8.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.14M | -8.64M | -6.38M | -2.77M | -483.00K |
| Issuance of Common Stock | 129.00K | 111.00K | 111.00K | 10.43M | 10.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.00K | 410.00K | 191.00K | 191.00K | -465.00K |
| Cash from Financing | -11.00M | -8.82M | -6.78M | 7.14M | 8.79M |
| Foreign Exchange rate Adjustments | 65.00K | 65.00K | 0.00 | 34.00K | -58.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.86M | 37.22M | 59.95M | 4.90M | 614.00K |